120 related articles for article (PubMed ID: 38811363)
21. Prognostic Value of Pre-Autologous Stem Cell Transplantation PET/CT in Diffuse Large B-Cell Lymphoma: The Deauville Score Is Prognostically Superior to ΔSUVmax.
Zhang XY; Song L; Wang PJ; Wang L; Li Y; Wang YY; Shi CL
Acta Haematol; 2020; 143(2):124-130. PubMed ID: 31382264
[TBL] [Abstract][Full Text] [Related]
22.
Burggraaff CN; Eertink JJ; Lugtenburg PJ; Hoekstra OS; Arens AIJ; de Keizer B; Heymans MW; van der Holt B; Wiegers SE; Pieplenbosch S; Boellaard R; de Vet HCW; Zijlstra JM;
J Nucl Med; 2022 Jul; 63(7):1001-1007. PubMed ID: 34675112
[TBL] [Abstract][Full Text] [Related]
23. Different predictive values of interim
Kim J; Lee JO; Paik JH; Lee WW; Kim SE; Song YS
Ann Nucl Med; 2017 Jan; 31(1):1-11. PubMed ID: 27627889
[TBL] [Abstract][Full Text] [Related]
24. An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.
Itti E; Meignan M; Berriolo-Riedinger A; Biggi A; Cashen AF; Véra P; Tilly H; Siegel BA; Gallamini A; Casasnovas RO; Haioun C
Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1312-20. PubMed ID: 23649463
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of interim ¹⁸F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma.
Yang DH; Min JJ; Song HC; Jeong YY; Chung WK; Bae SY; Ahn JS; Kim YK; Bom HS; Chung IJ; Kim HJ; Lee JJ
Eur J Cancer; 2011 Jun; 47(9):1312-8. PubMed ID: 21334197
[TBL] [Abstract][Full Text] [Related]
26. Validation of the ΔSUV
Itti E; Blanc-Durand P; Berriolo-Riedinger A; Kanoun S; Kraeber-Bodéré F; Meignan M; Gat E; Gouill SL; Casasnovas RO; Bodet-Milin C
J Nucl Med; 2023 Nov; 64(11):1706-1711. PubMed ID: 37734837
[TBL] [Abstract][Full Text] [Related]
27. Interim FDG
Duarte S; Roque A; Saraiva T; Afonso C; Marques BA; Lima CB; Neves D; Lai AC; Costa G; Cipriano A; Geraldes C; Ruzickova L; Carda JP; Gomes M
Clin Lymphoma Myeloma Leuk; 2023 Feb; 23(2):e107-e116. PubMed ID: 36567213
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of the feasibility and prognostic value of circulating tumor DNA monitoring in detecting gene mutations in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell therapy].
Zhou LH; Feng YQ; Hu YX; Huang H
Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):805-812. PubMed ID: 38049331
[No Abstract] [Full Text] [Related]
29. The Prognostic Utility of
Li C; Yu H; Chen X; Han S; Peng S; Lei T; Yang H
Front Oncol; 2022; 12():772773. PubMed ID: 35677166
[TBL] [Abstract][Full Text] [Related]
30. Circulating-tumor DNA Assessment in Diffuse Large B-cell Lymphoma to Determine Up-front Stem Cell Transplantation: A Pilot Study.
Kim J; LE TM; Lee D; Nguyen HDT; Cho HJ; Sohn SK; Kim JG; Jeong SY; Ham JY; Jeong JY; Han HS; Moon JH; Baek DW
In Vivo; 2024; 38(1):372-379. PubMed ID: 38148060
[TBL] [Abstract][Full Text] [Related]
31. Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).
Mamot C; Klingbiel D; Hitz F; Renner C; Pabst T; Driessen C; Mey U; Pless M; Bargetzi M; Krasniqi F; Gigli F; Hany T; Samarin A; Biaggi C; Rusterholz C; Dirnhofer S; Zucca E; Martinelli G
J Clin Oncol; 2015 Aug; 33(23):2523-9. PubMed ID: 26150440
[TBL] [Abstract][Full Text] [Related]
32. [Values of Different Evaluation Criteria of Interim
Zhu LT; Cen XN; Ou JP; Qiu ZX; Wang LH; Liu W; Wang WS; Dong YJ; Liang ZY; Wang MJ; Xu WL; Sun YH; Wang Q; Yin Y; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):431-437. PubMed ID: 28446288
[TBL] [Abstract][Full Text] [Related]
33. [Diagnostic and Prognostic Value of
Chen X; Qiao WL; Song JH; Liu CC; Han L; Wu S; Zhao JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1044-1049. PubMed ID: 37551475
[TBL] [Abstract][Full Text] [Related]
34. Next-generation sequencing-based detection of circulating tumour DNA After allogeneic stem cell transplantation for lymphoma.
Herrera AF; Kim HT; Kong KA; Faham M; Sun H; Sohani AR; Alyea EP; Carlton VE; Chen YB; Cutler CS; Ho VT; Koreth J; Kotwaliwale C; Nikiforow S; Ritz J; Rodig SJ; Soiffer RJ; Antin JH; Armand P
Br J Haematol; 2016 Dec; 175(5):841-850. PubMed ID: 27711974
[TBL] [Abstract][Full Text] [Related]
35. Baseline
Jing F; Liu Y; Zhao X; Wang N; Dai M; Chen X; Zhang Z; Zhang J; Wang J; Wang Y
EJNMMI Res; 2023 Oct; 13(1):92. PubMed ID: 37884763
[TBL] [Abstract][Full Text] [Related]
36. Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography.
Vishnu P; Wingerson A; Lee M; Mandelson MT; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):631-636. PubMed ID: 28684378
[TBL] [Abstract][Full Text] [Related]
37. Interim PET/CT based on visual and semiquantitative analysis predicts survival in patients with diffuse large B-cell lymphoma.
Li X; Sun X; Li J; Liu Z; Mi M; Zhu F; Wu G; Lan X; Zhang L
Cancer Med; 2019 Sep; 8(11):5012-5022. PubMed ID: 31293092
[TBL] [Abstract][Full Text] [Related]
38. Risk Assessment in Diffuse Large B-Cell Lymphoma by Combining Baseline Metabolic Tumor Volume and Peking Criteria When Evaluating Series
Yuan T; Zhang Y; Chen X; Wei M; Zhu H; Song Y; Yang Z; Zhu J; Wang X
Front Oncol; 2022; 12():876581. PubMed ID: 35530320
[TBL] [Abstract][Full Text] [Related]
39. Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma.
Fuertes S; Setoain X; Lopez-Guillermo A; Carrasco JL; Rodríguez S; Rovira J; Pons F
Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):496-504. PubMed ID: 23344136
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of therapeutic effect and prognostic value of
Zhao W; Wu X; Huang S; Wang H; Fu H
EJNMMI Res; 2024 Feb; 14(1):20. PubMed ID: 38372908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
